2Xideas »

Halozyme Therapeutics shares owned by 2Xideas

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by 2Xideas from 13F filings

Historical chart of 2Xideas investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by 2Xideas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by 2Xideas

Quarter filed Position value Share count Share price at filing
2023-12-31 $20M 544k 36.96
2023-09-30 $23M 601k 38.20
2023-06-30 $23M 645k 36.07
2023-03-31 $21M 548k 38.19
2022-12-31 $24M 417k 56.90
2022-09-30 $9.0M 227k 39.54
2022-06-30 $14M 325k 44.00